» Articles » PMID: 23900503

Seroprevalence of Hepatitis B Virus and Human Immunodeficiency Virus Among Young Prisoners

Overview
Journal J Res Med Sci
Specialty General Medicine
Date 2013 Aug 1
PMID 23900503
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Juveniles in custody are affected by sexually transmitted infections due to risky behaviors. Therefore, they have a disproportionate burden of hepatitis B virus (HBV) and human immunodeficiency virus (HIV). In this study, the prevalence and associated characteristics of hepatitis B and HIV infections were assessed in young prisoners.

Materials And Methods: In this cross-sectional study, prevalence of HBV and HIV infections was assessed among young prisoners during 2008-2009. A checklist consisting of demographic, social, and risk factors was filled out and blood was drawn for their tests. Sera were analyzed for hepatitis B surface antigen (HBs Ag), hepatitis B surface antibody (HBs Ab), hepatitis B core antibody (HBc Ab) and HIV Ab, and Western blot test was performed on antibody-positive HIV.

Results: A total number of 160 young prisoners (147 boys and 13 girls) were evaluated. The mean age of the subjects was 16.59 ± 1.24 year. HBs Ag, HBc Ab, HBs Ab, and HIV Ab were detected in 1 (0.63%), 1 (0.63%), 52 (32.5%), and 1 (0.63%), respectively.

Conclusion: With respect to national vaccination program against HBV infection, the juvenile prisoners had low prevalence of HBs Ab.

Citing Articles

Human immunodeficiency virus and viral hepatitis among high-risk groups: Understanding the knowledge gap in the Middle East and North Africa Region.

Melhem N, Rahhal N, Charide R, Kreidieh K, El-Khatib R World J Hepatol. 2015; 7(25):2619-30.

PMID: 26557955 PMC: 4635148. DOI: 10.4254/wjh.v7.i25.2619.


Comment on: Seroprevalence of hepatitis B virus and human immunodeficiency virus among young prisoners.

Kabir A J Res Med Sci. 2015; 20(2):206.

PMID: 25983778 PMC: 4400720.

References
1.
Butler T, Belcher J, Champion U, Kenny D, Allerton M, Fasher M . The physical health status of young Australian offenders. Aust N Z J Public Health. 2008; 32(1):73-80. DOI: 10.1111/j.1753-6405.2008.00169.x. View

2.
Mir-Nasseri M, Mohammadkhani A, Tavakkoli H, Ansari E, Poustchi H . Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users. Hepat Mon. 2011; 11(1):19-22. PMC: 3206659. View

3.
Templeton D . Sexually transmitted infection and blood-borne virus screening in juvenile correctional facilities: a review of the literature and recommendations for Australian centres. J Clin Forensic Med. 2005; 13(1):30-6. DOI: 10.1016/j.jcfm.2005.05.007. View

4.
Pallas J, Farinas-Alvarez C, Prieto D, Llorca J, Delgado-Rodriguez M . Risk factors for monoinfections and coinfections with HIV, hepatitis B and hepatitis C viruses in northern Spanish prisoners. Epidemiol Infect. 1999; 123(1):95-102. PMC: 2810732. DOI: 10.1017/s0950268899002538. View

5.
Adoga M, Banwat E, Forbi J, Nimzing L, Pam C, Gyar S . Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. J Infect Dev Ctries. 2009; 3(7):539-47. DOI: 10.3855/jidc.472. View